Innospec (IOSP) to Release Earnings on Tuesday

Key Points

• Innospec (NASDAQ:IOSP) is set to release its Q2 2025 earnings on August 5th, with anticipated earnings of $1.23 per share and revenue of $440.70 million.
• The company recently increased its semi-annual dividend from $0.79 to $0.84, providing a yield of 1.7% despite a high payout ratio of 155.56%.
• Insider Leslie J. Parrette sold 446 shares at an average price of $90.63, which represents a 7.50% reduction in their ownership stake.

Innospec (NASDAQ:IOSP - Get Free Report) is projected to announce its Q2 2025 earnings results after the market closes on Tuesday, August 5th. Analysts expect the company to announce earnings of $1.23 per share and revenue of $440.70 million for the quarter.

Innospec (NASDAQ:IOSP - Get Free Report) last posted its earnings results on Thursday, May 8th. The specialty chemicals company reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.02. Innospec had a net margin of 1.51% and a return on equity of 11.38%. The firm had revenue of $440.80 million during the quarter, compared to analyst estimates of $466.50 million. During the same quarter in the prior year, the business posted $1.75 EPS. The business's revenue was down 11.9% compared to the same quarter last year. On average, analysts expect Innospec to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Innospec Price Performance

Shares of NASDAQ IOSP traded down $1.35 during trading on Friday, hitting $78.55. The stock had a trading volume of 238,504 shares, compared to its average volume of 204,368. Innospec has a 12 month low of $77.58 and a 12 month high of $128.35. The company has a market capitalization of $1.96 billion, a PE ratio of 72.73 and a beta of 1.05. The firm has a fifty day moving average of $85.40 and a two-hundred day moving average of $94.10.

Insider Activity

In other Innospec news, Director Leslie J. Parrette sold 446 shares of the company's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $90.63, for a total transaction of $40,420.98. Following the sale, the director directly owned 5,497 shares of the company's stock, valued at $498,193.11. This represents a 7.50% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.31% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Innospec

Several institutional investors have recently added to or reduced their stakes in IOSP. Baird Financial Group Inc. lifted its holdings in Innospec by 11.5% during the first quarter. Baird Financial Group Inc. now owns 2,170 shares of the specialty chemicals company's stock valued at $206,000 after purchasing an additional 223 shares during the last quarter. NewEdge Advisors LLC lifted its holdings in shares of Innospec by 37.4% in the first quarter. NewEdge Advisors LLC now owns 4,567 shares of the specialty chemicals company's stock worth $433,000 after buying an additional 1,243 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Innospec by 4.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,833 shares of the specialty chemicals company's stock worth $1,405,000 after buying an additional 645 shares in the last quarter. Jane Street Group LLC lifted its holdings in shares of Innospec by 1,551.5% in the first quarter. Jane Street Group LLC now owns 95,243 shares of the specialty chemicals company's stock worth $9,024,000 after buying an additional 89,476 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Innospec by 14.3% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 101,773 shares of the specialty chemicals company's stock worth $9,643,000 after buying an additional 12,755 shares in the last quarter. 96.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Seaport Res Ptn upgraded shares of Innospec from a "hold" rating to a "strong-buy" rating in a research note on Monday, April 21st. Wall Street Zen lowered shares of Innospec from a "buy" rating to a "hold" rating in a research note on Tuesday, May 6th.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.